Dendritic cells (DCs) release exosomes with different characteristics based on stimulus. Here, we showed that DC cultures stimulated with low-level IFNγ released exosomes (IFNγ-DC-Exos) that contained microRNA species that can increase baseline myelination, reduce oxidative stress, and improve remyelination following acute lysolecithin-induced demyelination. Furthermore, nasally administered IFNγ-DC-Exos increased CNS myelination in vivo. IFNγ-DC-Exos were preferentially taken up by oligodendrocytes, suggesting that they directly impact oligodendrocytes to increase myelination. Thus, our results show great potential for use of these IFNγ-DC-Exos as a therapeutic to promote remyelination in multiple sclerosis and dysmyelinating syndromes.
Introduction
Multiple sclerosis (MS) is an inflammatory disorder involving myelin damage and oligodendrocyte loss. Though patients initially present with a relapsing-remitting disease course during which they have limited ability to remyelinate, over time this ability is diminished and they enter a secondary progressive stage where remyelination declines. With over 400,000 people currently suffering from MS in the United States, it is a significant and devastating healthcare burden (Hogancamp et al., 1997) . Damage to cortical structures -that is, grey matter demyelination -is a significant contributor to MS pathogenesis. Though grey matter atrophy is present in early stages as well, hippocampal demyelination and subsequent degeneration are especially common in progressive stages (Geurts et al., 2007; Pirko et al., 2007) . This study utilizes hippocampal slice cultures, an ex vivo system that closely parallels its in vivo counterpart and allows for assessment of changes in grey matter myelin.
Treatment options for MS are limited, and consist of conventional immunosuppressors, immunomodulators, or agents to prevent lymphocyte infiltration into the CNS (Ehling et al., 2010) . All current treatments induce harmful immune sequelae, and do little to promote repair. Instead, we suggest use of exosomes, naturally occurring, biologically active nanovesicles (30-120 nm) that are exported by cells and can be easily delivered across the blood brain barrier (El Andaloussi et al., 2013) , as an adjunct approach to increase remyelination postinjury.
Exosomes are released from a variety of cell types via the endocytic pathway and play important roles in physiologic cell function and disease states (Corrado et al., 2013) , and modulation of the immune system (Li et al., 2006) . While their exact function in these diverse activities is not yet fully understood, they exert influence through delivery of microRNAs, mRNAs and proteins to recipient cells (Bobrie et al., 2011) . Since exosomes do not provoke adverse immune reactions and are non-toxic, research to date has focused on exploiting these naturally formed nanovesicles by re-engineering them as specific immunomodulators and novel delivery platforms for the development of cancer therapeutics (Rountree et al., 2011) and vaccines (Hartman et al., 2011) .
The composition of exosomes differs depending on their cellular origin. Dendritic cells (DC), professional antigen presenting cells which are key in modulating adaptive immune responses, are a source of exosomes which can be scalable in vitro (Yin et al., 2013) . DC-derived exosomes differ in their composition depending on external stimuli and cell state (Montecalvo et al., 2012) . For example, there are vast differences in the miRNA content of exosomes secreted from immature versus mature lipopolysaccharide-stimulated DCs (Montecalvo et al., 2012) .
In this study, we stimulated primary DC cultures with low level IFNγ, as we have recently shown that phasic stimulation with low-level IFNγ significantly increases myelination in cultured brain slices or when administered nasally to animals (Pusic and Kraig, in press). Though others have used IFNγ to produce exosomes expressing surface markers that Journal of Neuroimmunology 266 (2014) 12-23 
